In severe chronic rhinosinusitis with polyps and asthma, dupilumab improved nasal polyp score and sense of smell vs. omalizumab at 24 wk

Authors

Institutions

Publication Details

Journal
Annals of Internal Medicine
Published
2026-02-01
DOI
https://doi.org/10.7326/annals-25-05457-jc
Primary Topic
Sinusitis and nasal conditions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In severe chronic rhinosinusitis with polyps and asthma, dupilumab improved nasal polyp score and sense of smell vs. omalizumab at 24 wk

Derek Chu, Matthew A. Rank
Annals of Internal Medicine
Sinusitis and nasal conditions
article

In severe chronic rhinosinusitis with polyps and asthma, dupilumab improved nasal polyp score and sense of smell vs. omalizumab at 24 wk

Derek Chu, Matthew A. Rank
article en

Abstract

No abstract available for this paper.
Annals of Internal MedicineVol. 179(2)
Mayo Clinic in Arizona (US), McMaster University (CA)
Zero hunger
Openalex Percentile: Top 69%
Sinusitis and nasal conditions
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

In severe chronic rhinosinusitis with polyps and asthma, dupilumab improved nasal polyp score and sense of smell vs. omalizumab at 24 wk — Derek Chu, Matthew A. Rank · Annals of Internal Medicine (2026) | TGRS Research Map | TGRS